E
Nuvectis Pharma, Inc. NVCT
$9.44 -$0.05-0.53%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Total Cash And Short-Term Investments 18.53M 17.17M 18.12M 19.46M 19.13M
Total Receivables -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- --
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 74.00K 138.00K 182.00K 250.00K 59.00K
Total Current Assets 18.61M 17.31M 18.30M 19.71M 19.19M

Total Current Assets 18.61M 17.31M 18.30M 19.71M 19.19M
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles -- -- -- -- --
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets -- -- -- -- --
Total Assets 18.61M 17.31M 18.30M 19.71M 19.19M

Total Accounts Payable 2.50M 2.26M 1.85M 1.76M 2.77M
Total Accrued Expenses 6.40M 4.06M 3.92M 3.93M 4.21M
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities -- -- -- -- --
Total Other Current Liabilities -- -- -- -- --
Total Current Liabilities 8.89M 6.32M 5.77M 5.69M 6.98M

Total Current Liabilities 8.89M 6.32M 5.77M 5.69M 6.98M
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities -- -- -- -- --
Total Liabilities 8.89M 6.32M 5.77M 5.69M 6.98M

Common Stock & APIC 82.96M 77.99M 75.37M 72.44M 66.45M
Retained Earnings -73.25M -67.00M -62.84M -58.42M -54.25M
Treasury Stock & Other -- -- -- -- --
Total Common Equity 9.71M 10.99M 12.53M 14.02M 12.20M

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- --
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- --

Total Common Equity 9.71M 10.99M 12.53M 14.02M 12.20M
Total Preferred Equity -- -- -- -- --
Total Minority Interest -- -- -- -- --
Total Equity 9.71M 10.99M 12.53M 14.02M 12.20M

Weiss Ratings